Answers are grounded in this paper and cite their sources.
The carrier-mediated dry-powder inhaler of rifampicin could serve as an improved and efficient system for local targeting of drugs into the lungs.
No takes yet. Share an insight, caveat, or question.
Rawal et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: